Akari Therapeutics (AKTX) Profit After Tax (QoQ) (2014 - 2026)
Akari Therapeutics (AKTX) Profit After Tax (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172.84% |
| Dec 31, 2025 | 17.22% |
| Sep 30, 2025 | -237.73% |
| Jun 30, 2025 | 48.85% |
| Mar 31, 2025 | 97.35% |
| Dec 31, 2024 | -4,735.68% |
| Sep 30, 2024 | 61.70% |
| Jun 30, 2024 | -35.79% |
| Mar 31, 2024 | -34.51% |
| Dec 31, 2023 | -44.13% |
| Sep 30, 2023 | 28.23% |
| Jun 30, 2023 | -499.60% |
| Dec 31, 2020 | -845.51% |
| Sep 30, 2020 | 112.28% |
| Jun 30, 2020 | -98.64% |
| Mar 31, 2020 | 52.17% |
| Dec 31, 2019 | -171.70% |
| Sep 30, 2019 | 51.55% |
| Jun 30, 2019 | -3,088.97% |
| Mar 31, 2016 | -146.13% |